Evidence map›Paper›PMID 35300329›Full record

ArticleFrontiers in immunology2022

CpG Single-Site Methylation Regulates TLR2 Expression in Proinflammatory PBMCs From Apical Periodontitis Individuals.

María José Bordagaray, Alejandra Fernández, Jessica Astorga, Mauricio Garrido, Patricia Hernández, Alejandra Chaparro, María Jesús Lira, Peter Gebicke-Haerter, Marcela Hernández

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. The computational power of the human brain.Frontiers in cellular neuroscience · 2023
    Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

María José BordagarayLaboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
Alejandra FernándezLaboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
Jessica AstorgaLaboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
Mauricio GarridoLaboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
Patricia HernándezLaboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
Alejandra ChaparroDepartment of Periodontology, Faculty of Dentistry, Centro de Investigación e Innovación Biomédica (CIIB), Universidad de Los Andes, Santiago, Chile.
María Jesús LiraDepartment of Orthopedic Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile.
Peter Gebicke-HaerterInstitute of Psychopharmacology, Central Institute of Mental Health, Faculty of Medicine, University of Heidelberg, Mannheim, Germany.
Marcela HernándezLaboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.
University of Chile · CLCentral Institute of Mental Health · DEPontificia Universidad Católica de Chile · CLUniversidad Andrés Bello · CLUniversidad de Los Andes, Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Apical periodontitis (AP) is a common oral disease caused by the inflammatory destruction of the periapical tissues due to the infection of the root canal system of the tooth. It also contributes to systemic bacterial translocation, where peripheric mononuclear blood cells (PBMCs) can act as carriers. Toll-like receptor (TLR) 2 mediates the response to infection and activates inflammatory responses. DNA methylation can be induced by bacteria and contributes to the modulation of this response. Despite the evidence that supports the participation of PBMCs in immune-inflammatory disorders, the inflammatory profile and epigenetic regulatory mechanisms of PBMCs in AP individuals are unknown. Aim: To determine TLR2 gene methylation and inflammatory profiles of PBMCs in AP. Methods: Cross-sectional exploratory study. Otherwise, healthy individuals with AP (n=27) and controls (n=30) were included. PMBCs were isolated by a Ficoll gradient, cultured for 24 hours, and both RNA and DNA were extracted. DNA was bisulfite-treated, and specific sites at the promoter region of the TLR2 gene were amplified by qPCR using validated primers. To verify its amplification, agarose gels were performed. Then, the PCR product was sequenced. mRNA expression of TLR2 was determined by qPCR. The soluble levels of 105 inflammatory mediators were first explored with Proteome Profiler Human Cytokine Array Kit. Consequently, tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, IL-6Rα, IL-1β, and IL-12p70 levels were measured by Multiplex assay. Results: PBMCs from individuals with AP demonstrated a proinflammatory profile showing higher soluble levels of TNF-α, IL-6, and IL-1β compared to controls (p<0.05). Higher TLR2 expression and higher global methylation pattern of the promoter region of the gene were found in AP compared to controls (p<0.05). The CpGs single-sites at positions -166 and -146 were completely methylated, while the site -102 was totally unmethylated, independently of the presence of AP. DNA methylation of CpG single-sites in positions -77 and +24 was positively associated with TLR2 expression. Conclusions: PBMCs from AP subjects show a hyperinflammatory phenotype and TLR2 upregulation in association with single CpG-sites' methylation from the TLR2 gene promoter, thereby contributing to a sustained systemic inflammatory load in individuals with periapical endodontic diseases.

Indexed as

Periapical PeriodontitisToll-Like Receptor 2Blood CellsCross-Sectional StudiesDNA MethylationHumansInterleukin-6Tumor Necrosis Factor-alphaInterleukin-6TLR2 protein, humanToll-Like Receptor 2Tumor Necrosis Factor-alphaCpG islandDNA methylationleukocytesmononuclearperiapical periodontitisRNA messengertoll-like receptor 2

Identifiers

PMID35300329
PMCPMC8921253
OpenAlexW4214773848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.